SPHK2 and prostate carcinoma: As demonstrated, the mRNA expression of both SphK1 and SphK2 was significantly elevated in human prostate cancer tissues (“T”) from 10 different CRPC patients (tissues were provided by Dr. Mi [17]) (Fig. 1C).